Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/1336D8A9EF96471E5E3A974A09B6319EF0BFDC93B33D263489F0C0D2501E8ADF8D71C3BA92FAF62D9DBA4E941C24F2A4http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/1336D8A9EF96471E5E3A974A09B6319EF0BFDC93B33D263489F0C0D2501E8ADF8D71C3BA92FAF62D9DBA4E941C24F2A4http://www.w3.org/2000/01/rdf-schema#comment"Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator); In a Japanese population CES2 haplotypes and a defective allele were associated with a decrease in enzyme levels or activity. Pharmacokinetics of irinotecan was evaluated in cancer patients."xsd:string
http://purl.uniprot.org/uniprot/#_A41AC9588E5A0B69661AAF264769D7B5FCB04FC78C034E55A319966D42057FD65E94E16089E186909B22E93C489315A4http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/1336D8A9EF96471E5E3A974A09B6319EF0BFDC93B33D263489F0C0D2501E8ADF8D71C3BA92FAF62D9DBA4E941C24F2A4
http://purl.uniprot.org/uniprot/O00748http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/1336D8A9EF96471E5E3A974A09B6319EF0BFDC93B33D263489F0C0D2501E8ADF8D71C3BA92FAF62D9DBA4E941C24F2A4
http://purl.uniprot.org/uniprot/#_O00748-mappedCitation-17640957http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/1336D8A9EF96471E5E3A974A09B6319EF0BFDC93B33D263489F0C0D2501E8ADF8D71C3BA92FAF62D9DBA4E941C24F2A4